Events & conferences in the Life Sciences industry

Digital Event


We are pleased to announce the 2nd Annual European HealthTech CEO Forum (Digital & MedTech), which will take place on the 8th - 9th of March 2021 and be part of the Digital Sachs Spring Life Sciences Week, that will also incorporate the 14th Annual European Life Sciences CEO Forum. Due to the pandemic we have decided that for the first time Sachs Zurich events will be held in a digital format. This will allow us to support our community and past attendees. We will provide both the usual stimulating programme and the networking opportunities through the audio/video online meeting system. The main programme for the 2nd Annual EHTF is spread throughout 2 days (8th-9th of March) and will include HealthTech Innovation Day, focusing on Investment & Partnership in MedTech and Digital Health, and Pandemic Response Day, focusing on new developments in tackling pandemic. The programme will feature topical keynotes and panels with industry leaders as well as over 20 corporate presentations by public, private and growth companies, plus over 20 pitches by seed companies. We anticipate 300+ delegates, including major and growth corporates, financial investors/partners, bankers and advisors. Meetings will take place from the 8th to 12th of March. Moreover, the system will be open for 12 hours a day and we expect 1500+ meetings completed over 5 days.

Online


Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world – Know how to assess and calculate the value of a biotech company – Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal.

Digital Event


We are pleased to announce the 14th Annual European Life Sciences CEO Forum, which will take place on the 10th - 12th of March 2021 and be part of the Digital Sachs Spring Life Sciences Week, that will also incorporate the 2nd Annual European HealthTech CEO Forum. Due to the pandemic we have decided that for the first time Sachs Zurich events will be held in a digital format. This will allow us to support our community and past attendees. We will provide both the usual stimulating programme and the networking opportunities through the audio/video online meeting system. Back for its 14th Annual Edition, this global bio-pharma industry event will address through its programme the main challenges for 2021 in investment, partnering and alliance management. Key players contribute their insights in panels which cover the macro picture as well as innovation in different therapeutic sectors. The main programme for the 14th Annual ELSF is spread throughout 2 days (10th-11th of March) and will include BioCapital & Investment Day and Bio-Pharma Partnering & Therapeutics Day. The two days will feature more than 14 hours of high-level speeches, panel discussions and spotlight showcases by leading industry corporates. In addition, there is a global company showcase of 50+ presentations by established public, private, emerging and seed companies, offering innovative solutions and seeking investment and partnering opportunities. We anticipate 400+ delegates will register for the forum from all Life Sciences sectors, with the target audience being corporate and financial investors/partners, bankers and advisors. Meetings will take place from the 8th to 12th of March. Moreover, the system will be open for 12 hours a day and we expect 1500+ meetings completed over 5 days.

Online


Life Science Nation (LSN) Healthtech Partnering Week hosts three back-to-back digital partnering conferences: Redefining Early Stage Investments (RESI), 4D Meets AI, and Longevity, Health & Innovation (LHI). These digital partnering conferences function as a healthcare event trifecta, providing opportunities for early-stage start-ups to connect with investors and strategic partners based on product fit and stage of development. RESI has a longstanding reputation for bringing life science deal-makers together, while 4D Meets AI creates a distinct setting for those advancing drugs, devices, diagnostics, and digital health through AI technology, and LHI is the ultimate meeting of the minds in the longevity and age-tech industries through its early-stage partnering platform, as well as timely market overviews with industry leaders. Each conference provides a unique solution to connecting buyers and sellers in life science and healthcare, and we hope you’ll join us!

Online


The fifteenth annual BIO-Europe Spring® premier springtime partnering conference will be held March 22-25 in a fully digital format. It will include on-demand early access to the company pitches, program sessions, and sponsor and showcase company content up to five weeks prior to the live event for the best possible networking and meeting decisions once partnering begins.

Malmo Sweden

Nordic life science partnering at its best. Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends.Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and healthtech but also from finances, research, policy and regulatory authorities. Based on cutting-edge and advanced partnering and networking tools, Nordic Life Science Days showcases the best the Nordic region has to offer.

Digital Event


The programme for the 4th Annual NIF will be spread throughout 3 days. Featuring more than 17 hours of high-level speeches, panel discussions and spotlight showcases by leading industry corporates. The target audience for this event are buy and sell-side analysts from investment banks and funds, as well as partnering executives from pharma, biotech and medtech companies. We anticipate over 300 delegates and 35+ company presentations by established listed, private and emerging companies.

Online


Biotechgate Digital Partnering is a virtual conference designed to support the business development of Biotech, Medtech and Pharma companies. Join four days of digital partnering and establish new global connections thanks to pre-arranged one-on-one ZOOM meetings.

Online and Live
Shanghai China

Engage with the largest network of potential partners to accelerate your cross-border strategies and expand your reach into the China market 2 days in-person, 3 days virtually. This year's hybrid event enables you to identify, meet and network with leaders across the life science value chain.

Online


Bio€quity Europe is the industry’s premier international showcase for financial dealmakers and pharmaceutical executives to assess and network with rising biotechs. For the 21st anniversary meeting, more than 80 hand-picked companies will present their stories and participate in the thought-leading program. The agenda will allow for maximum financial networking through both ample breaks, receptions, and 1x1 meetings using EBD Group’s partneringONE® conference networking solution. Don’t miss this opportunity to potentially find your next blockbuster investment or partnership opportunity.

The 7th Annual Immuno-Oncology Innovation Forum (#Sachs_IOIF) will take place on the 18th-20th of May 2021. Due to the pandemic, the #Sachs_IOIF event will be once again hosted in a digital format. This will allow us to further support our community and past attendees, bridging Europe and the US. We will provide both the usual stimulating program and networking opportunities through our online video and audio meeting system. The programme for the 7th Annual IOIF will be spread throughout 3 days. Featuring more than 14 hours of keynotes, high-level speeches, panel discussions and spotlight showcases by leading corporates. The event brings together leaders from pharma and biotech as well as cancer research institutes, patient advocacy groups, early and late-stage investors, CMOs and CROs. We anticipate over 300 delegates and 25+ company presentations by established listed, private and emerging companies. Over half of the attendees are corporate and financial investors, buy-side and sell-side analysts, bankers, legal and business advisors. As usual, the forum will include an Online Meeting System, which creates a number of networking opportunities for attendees with meeting hosted for a whole week of the conference, from 17th to 21st of May. The system will be open for 24 hours each day to accommodate meeting scheduling for attendees from around the globe. When you will log in to the Online Meeting System for the first time you will be asked to block times that do not suite you to avoid arising conflicts. Sachs support team will be available during conference hours to assist you.

Online


Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world – Know how to assess and calculate the value of a biotech company – Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal.

Online


BIO Digital is the world's largest virtual biotech partnering and education event, convening thousands of global biotech leaders and innovators. New this year, select programming will be available the week prior to BIO Digital Week. Attendees can engage in pre-event programming and networking opportunities, and meet new companies to request meetings with in BIO One-on-One Partnering.

London UK

The OBN Awards celebrate outstanding achievement across the life sciences industry. During the evening we aim to shine a light on companies at all stages of development, recognising inspirational leadership, exciting innovation, novel and exciting approaches to unmet clinical need, outstanding company progression and the delivery of real-life tangible results.

Oxford UK

BioForward is a full-day event designed to be a practical, ‘one-stop-shop’ that provides leaders of growing Life Sciences companies with the knowledge, skills, connectivity, and services necessary to achieve sustainable commercial success.

Online & London
UK

BioTrinity is a highly regarded two-day biopartnering & investment life sciences conference, that aims to shine a light on new innovation in the life sciences industry and inspire growth and create opportunities for all who attend. The 2021 event will be delivered in a true hybrid format, and will provide seamless LIVE interaction for delegates, who include early-stage and emerging biotech, medtech and digital health companies, big pharma executives, life sciences investors and service providers. BioTrinity 2021 will be delivered LIVE in a HYBRID format at etc. venues Bishopsgate, London and via a dedicated virtual platform on Monday 21 & Tuesday 22 June in person, with the virtual platform available until Friday 25 June. All platforms will be linked, so no matter how you are experiencing the event, your access to content, networking, partnering and knowledge sharing will be the same.

Lithuanian Exhibition and Congress centre
Vilnius Lithuania

Life Sciences Baltics is the only and finest Baltics’ life sciences forum gathering global biotechnology, pharmaceutical and medical devices leaders. Forum provides a unique programme that features a variety of opportunities to get insights and seek process of life sciences through the conference, plenary and educational sessions, potential one-on-one meetings and scientific posters area. Discover Lithuania and the Baltics as a potential gateway to emerging markets in a global life sciences’ landscape.

Palacio de Baluarte in Pamplona
Navarro Spain

BIOSPAIN is the largest biotech event organized by a national bioindustry association in Europe and one of the largest in the world by the number of one-to-one meetings (+3.300) and companies participating (+773). 34% of our delegates came from outside of Spain. Since 1999, the Spanish Bioindustry Association (AseBio) worked to achieve positive political and economic changes that promote and boost the development of the Spanish biotechnology industry. In order to do this, AseBio works closely with regional, national and European legislative bodies, as well as with all those social organisations that are committed to using biotechnology to improve citizens’ quality of life, environmental sustainability, economic development and skilled job creation.